Last checked at 11 Nov 2014 07:00
For immediate release | 11 November 2014 |
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in April 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans.
The table below provides further detail.
Name of company: | Futura Medical plc
|
Name of scheme: | Unapproved Share Option Scheme ("USOS")
EMI Share Option Scheme ("EMI")
|
Period of return: | From: 28 April 2014To: 10 November 2014
|
Number and class of securities not issued under the scheme(s) | USOS: 1,786,435 ordinary shares of 0.2p EMI: 1,828,306 ordinary shares of 0.2p Total: 3,614,741
|
Number of securities issued under the scheme(s) during the period | USOS: Nil EMI: Nil
|
Balance under the scheme(s) of securities not yet issued at the end of the period | USOS: 1,786,435 EMI: 1,828,306Total: 3,614,741
|
Number and class of securities originally admitted and the date of admission | USOS: 814,424 on 25 May 2011 and 1,193,959 on 8 October 2013Total: 2,008,383 Total
EMI: 1,520,576 on 25 May 2011 and 1,476,041 on 8 October 2013Total: 2,996,617 Total
Total: 5,005,000
|
Name of contact: | Derek Martin, Chief Financial Officer
|
Telephone number of contact: | +44 (0) 1483 685 670 |
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive
| Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Nominated Adviser: |
|
N+1 Singer Aubrey Powell | Tel:+44 (0)20 7496 3000 |
For media enquiries please contact: |
|
|
|
Buchanan |
|
Mark Court / Sophie Cowles | Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com